Novavax, Inc. (NVAX): Price and Financial Metrics
NVAX Price/Volume Stats
| Current price | $5.94 | 52-week high | $23.86 |
| Prev. close | $6.00 | 52-week low | $3.90 |
| Day low | $5.87 | Volume | 285,283 |
| Day high | $5.95 | Avg. volume | 4,829,604 |
| 50-day MA | $7.33 | Dividend yield | N/A |
| 200-day MA | $10.00 | Market Cap | 955.41M |
NVAX Stock Price Chart Interactive Chart >
Novavax, Inc. (NVAX) Company Bio
Novavax, Inc. focuses on discovering, developing, and commercializing recombinant nanoparticle vaccines and adjuvants. The company was founded in 1987 and is based in Gaithersburg, Maryland.
NVAX Price Returns
| 1-mo | -21.84% |
| 3-mo | -32.58% |
| 6-mo | -40.60% |
| 1-year | 49.62% |
| 3-year | -87.27% |
| 5-year | -72.20% |
| YTD | -26.12% |
| 2024 | 67.50% |
| 2023 | -53.31% |
| 2022 | -92.81% |
| 2021 | 28.30% |
| 2020 | 2,701.76% |
Continue Researching NVAX
Want to see what other sources are saying about Novavax Inc's financials and stock price? Try the links below:Novavax Inc (NVAX) Stock Price | Nasdaq
Novavax Inc (NVAX) Stock Quote, History and News - Yahoo Finance
Novavax Inc (NVAX) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...